Cormedix Inc (CRMD) Stock Price, Quote & News

Company Profile

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was in...

Industry: Biotechnology

Sector: Healthcare

Phone: 908 517 9500

Fax: 908 375 8272

Website: www.cormedix.com

Address:

300 Connell Drive, Suite 4200, Berkeley Heights, United States

btdb Jul. 9 at 11:01 PM

$CRMD $13.04 on 10/20/24! Down a $1.73 in almost 9 months. How is that even possible? ANYONE making estimates of where this stock will be in the future should ask themselves where they thought it would be by now last October. And that's with a successful product and rollout! JOE, WTF?

1 · Reply

Hamodeh Jul. 9 at 9:53 PM

$CRMD Tomorrow: a) $82 million will be used for working capital and acquisitions … Boring 🥱 $15 on cards b) $82 million will be used for future opp … Boring 🥱 $17 on cards c) $82 million will be used to buy Bitcoin … great 👍🏻 $50 on cards

1 · Reply

Hamodeh Jul. 9 at 9:49 PM

$CRMD I think best case scenario CRMD buying BTC .. $50 would be on cards

0 · Reply

Dr_Bearfvcker Jul. 9 at 9:48 PM

$CRMD Best case scenario is one of the LDOs has it written in their contract that CRMD maintains a certain amount of cash for operations and supply. That would send this rocketing.

1 · Reply

Hamodeh Jul. 9 at 9:46 PM

$CRMD please buy some BTC with that massive cash in hands

0 · Reply

Hamodeh Jul. 9 at 9:46 PM

$CRMD best guess $82 million from public offering will be Bitcoin treasury , joe buying BTC .. ….$50 will be in a second

0 · Reply

wheresthedog Jul. 9 at 8:51 PM

$CRMD This is good news

0 · Reply

TSLA_S3XY Jul. 9 at 8:15 PM

$CRMD Tomorrow We Get A PR About Attending HC Wainwright Conference 7/14. $AKBA Did This Today & Price Went Up 7%. Just Food For Thought.

2 · Reply

bustingmyask Jul. 9 at 8:12 PM

$CRMD Green is green ! Hope we get some continuation tomorrow .

0 · Reply

altair787 Jul. 9 at 7:57 PM

$CRMD An almost perfect drop into the EOD as CRMD continues its climb to mediocre status. We DO keep hoping the uptrend resumes, of course.

0 · Reply

CorMedix Analyst Says Investors Could Be Further Rewarded

Jun 30, 2025, 2:14 PM EDT - 9 days ago

CorMedix Seems Significantly Undervalued

Jun 27, 2025, 9:09 AM EDT - 12 days ago

Concentrix Posts Downbeat Earnings, Joins CorMedix And Other Big Stocks Moving Lower In Friday's Pre-Market Session

CNXC

Jun 27, 2025, 8:00 AM EDT - 12 days ago

CorMedix Inc. Announces Pricing of Public Offering of Common Stock

Jun 26, 2025, 4:01 PM EDT - 13 days ago

CorMedix Inc. Announces Proposed Public Offering of Common Stock

Jun 23, 2025, 7:30 AM EDT - 16 days ago

CorMedix inc. Announces Customer Implementation

Jun 5, 2025, 12:37 AM EDT - 4 weeks ago

CorMedix: DefenCath In Exponential Growth Phase With Robust Market Position

Jun 4, 2025, 12:41 PM EDT - 5 weeks ago

CorMedix: Exceeding Expectations

May 30, 2025, 8:30 AM EDT - 5 weeks ago

CorMedix Inc. To Participate In The Jefferies Global Healthcare Conference

May 15, 2025, 8:30 AM EDT - 7 weeks ago

CorMedix Inc. to Participate in the RBC Global Healthcare Conference

May 6, 2025, 11:59 AM EDT - 2 months ago

CorMedix, Inc. (CRMD) Q1 2025 Earnings Call Transcript

May 6, 2025, 7:30 AM EDT - 2 months ago

CorMedix Inc. Reports First Quarter 2025 Financial Results and Provides Business Update

Apr 29, 2025, 8:30 AM EDT - 2 months ago

CorMedix Inc. to Report First Quarter 2025 Financial Results and Provide a Corporate Update on May 6, 2025

Apr 8, 2025, 7:30 AM EDT - 3 months ago

Cormedix Inc. Announces Preliminary First Quarter 2025 Results and Raises H1 2025 Net Sales Guidance

Apr 2, 2025, 8:30 AM EDT - 3 months ago

CorMedix Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference

Mar 28, 2025, 3:01 AM EDT - 3 months ago

CorMedix: A Fair-Priced Biotech Company With A Bright Future

Mar 25, 2025, 10:51 AM EDT - 3 months ago

CorMedix Inc. (CRMD) Q4 2024 Earnings Call Transcript

Mar 25, 2025, 7:30 AM EDT - 3 months ago

CorMedix Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Mar 24, 2025, 9:21 AM EDT - 3 months ago

CorMedix Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Mar 18, 2025, 8:30 AM EDT - 4 months ago

CorMedix Inc. to Report Fourth Quarter and Full Year 2024 Financial Results and Provide a Corporate Update on March 25, 2025

Jan 7, 2025, 7:30 AM EST - 6 months ago

CorMedix Inc. Announces Preliminary Fourth Quarter 2024 Results and Provides Business Update

Dec 19, 2024, 8:30 AM EST - 7 months ago

CorMedix Inc. Added to Nasdaq Biotechnology Index

Nov 26, 2024, 8:30 AM EST - 8 months ago

CorMedix Inc. Supports CMS Policy Updates Regarding Access to Innovative Drug Products

Nov 8, 2024, 8:00 AM EST - 8 months ago

Stock Picks From Seeking Alpha's October 2024 New Analysts

ACGL AMCX AMPS APOG AVRE BHP BILL

Nov 4, 2024, 8:30 AM EST - 8 months ago

CorMedix Inc. to Participate in the Truist Securities BioPharma Symposium

Oct 30, 2024, 12:32 PM EDT - 9 months ago

CorMedix Inc. (CRMD) Q3 2024 Earnings Call Transcript

Oct 30, 2024, 7:30 AM EDT - 9 months ago

CorMedix Inc. Reports Third Quarter and Nine Month 2024 Financial Results and Provides Business Update

Oct 28, 2024, 1:33 PM EDT - 9 months ago

CorMedix 2.0: New Leadership, New Approval, New Focus

Oct 25, 2024, 2:30 PM EDT - 9 months ago

Undercovered Dozen: CorMedix, Cabaletta, Skyx Platforms, Dynex Capital +

Oct 24, 2024, 8:30 AM EDT - 9 months ago

CorMedix Inc. Announces New Data at ASN Kidney Week 2024

Oct 23, 2024, 8:30 AM EDT - 9 months ago

CorMedix Inc. to Report Third Quarter 2024 Financial Results and Provide a Corporate Update on October 30, 2024

Sep 13, 2024, 8:30 AM EDT - 10 months ago

CorMedix Inc. to Present at the Cantor Global Healthcare Conference

Sep 9, 2024, 10:52 AM EDT - 10 months ago

CorMedix Inc. Announces New Commercial Agreement

Aug 14, 2024, 2:08 PM EDT - 11 months ago

CorMedix Inc. (CRMD) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 7:30 AM EDT - 11 months ago

CorMedix Inc. Reports Second Quarter and Six Month 2024 Financial Results and Provides Business Update

Aug 7, 2024, 8:30 AM EDT - 1 year ago

CorMedix Inc. to Report Second Quarter 2024 Financial Results and Provide a Corporate Update on August 14, 2024

Jul 3, 2024, 8:00 AM EDT - 1 year ago

CorMedix Inc. Announces Outpatient Availability of DefenCath

Jun 6, 2024, 8:30 AM EDT - 1 year ago

CorMedix Inc. Announces CMS Grants Pass-Through Status to Defencath

May 28, 2024, 8:30 AM EDT - 1 year ago

CorMedix Inc. Announces Commercial Agreement With Top Tier Dialysis Provider

May 11, 2024, 5:48 PM EDT - 1 year ago

CorMedix Inc. (CRMD) Q1 2024 Earnings Call Transcript

May 10, 2024, 8:30 AM EDT - 1 year ago

CorMedix Inc. to Participate in Two Upcoming Investor Conferences

May 9, 2024, 7:30 AM EDT - 1 year ago

CorMedix Inc. Reports First Quarter 2024 Financial Results and Provides Business Update

btdb Jul. 9 at 11:01 PM

1 · Reply

Hamodeh Jul. 9 at 9:53 PM

1 · Reply

Hamodeh Jul. 9 at 9:49 PM

$CRMD I think best case scenario CRMD buying BTC .. $50 would be on cards

0 · Reply

Dr_Bearfvcker Jul. 9 at 9:48 PM

$CRMD Best case scenario is one of the LDOs has it written in their contract that CRMD maintains a certain amount of cash for operations and supply. That would send this rocketing.

1 · Reply

Hamodeh Jul. 9 at 9:46 PM

$CRMD please buy some BTC with that massive cash in hands

0 · Reply

Hamodeh Jul. 9 at 9:46 PM

$CRMD best guess $82 million from public offering will be Bitcoin treasury , joe buying BTC .. ….$50 will be in a second

0 · Reply

wheresthedog Jul. 9 at 8:51 PM

$CRMD This is good news

0 · Reply

TSLA_S3XY Jul. 9 at 8:15 PM

$CRMD Tomorrow We Get A PR About Attending HC Wainwright Conference 7/14. $AKBA Did This Today & Price Went Up 7%. Just Food For Thought.

2 · Reply

bustingmyask Jul. 9 at 8:12 PM

$CRMD Green is green ! Hope we get some continuation tomorrow .

0 · Reply

altair787 Jul. 9 at 7:57 PM

$CRMD An almost perfect drop into the EOD as CRMD continues its climb to mediocre status. We DO keep hoping the uptrend resumes, of course.

0 · Reply

JackSch Jul. 9 at 7:54 PM

$CRMD the market can’t get better than this for this punk 😀

0 · Reply

cosmogo Jul. 9 at 7:15 PM

$CRMD Get over the cloud

0 · Reply

altair787 Jul. 9 at 7:08 PM

$CRMD Usual EOD Slide appears

0 · Reply

winston319 Jul. 9 at 6:36 PM

$CRMD can we finish Green today or are they going to screw us in the end?

1 · Reply

bioisrisky Jul. 9 at 5:59 PM

$CRMD For some perspective, last year at this time we were in the 4s and just prior to q2 ER we were as low as 3.64 on 8/12. After ER we ran to the mid 13s until Nov ER stalled the momentum.

1 · Reply

Miketj Jul. 9 at 5:33 PM

$CRMD contemplating a quick flip🤔

2 · Reply

Dr_Bearfvcker Jul. 9 at 5:05 PM

$CRMD Bought a few hundred more. Now Im in as much as I want to be until Joe gives us an update. My average is well below those RBC assholes.

1 · Reply

Bigmike50 Jul. 9 at 4:51 PM

$CRMD Not much Volume by moving in the right direction. Lets hold the gains and start a winning streak.

0 · Reply

Stonehands Jul. 9 at 4:26 PM

$CRMD hmm XBI has good volume on a move up today. Start of rotation to bios?

1 · Reply

4ezmony Jul. 9 at 4:20 PM

$CRMD We need some volume! Que the volume! LFG!

0 · Reply

Bondra Jul. 9 at 3:26 PM

$TGTX $AKBA $CRMD $HROW $CAPR

0 · Reply

Notanissue Jul. 9 at 3:21 PM

$CRMD if someone took a a sizeable chunk of the offering, 5%+ of outstanding shares, they will have to report tomorrow.

2 · Reply

Market Cap	788.13M
Revenue (ttm)	43.47M
Net Income (ttm)	-17.93M
EPS (ttm)	N/A
PE Ratio	52.82
Forward PE	12.10
Profit Margin	-41.25%
Debt to Equity Ratio	0.00

Volume	1,131,800
Avg Vol	2,124,856
Day's Range	N/A - N/A
Shares Out	67.83M
Stochastic %K	2%
Beta	1.58
Analysts	Strong Sell
Price Target	$19.17